Van der Merwe, JL; Sacco, A; Toelen, J; Deprest, J; (2020) Long-term neuropathological and/or neurobehavioral effects of antenatal corticosteroid therapy in animal models: a systematic review. Pediatric Research , 87 pp. 1157-1170. 10.1038/s41390-019-0712-1.

Preview	Text (Journal article) Van der Merwe_SR_LTN_ACS_Animal_PedRes_final.pdf - Accepted Version Download (712kB) | Preview
Preview	Text (Supplementary information) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Suppl.pdf - Accepted Version Download (82kB) | Preview
Preview	Text (Table 1) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Table1.pdf - Accepted Version Download (122kB) | Preview
Preview	Text (Table 2) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Table2.pdf - Accepted Version Download (89kB) | Preview
Preview	Text (Table 3) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Table3.pdf - Accepted Version Download (121kB) | Preview
Preview	Text (Table 4) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Table4.pdf - Accepted Version Download (117kB) | Preview
Preview	Text (Figure 1) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Figure 1.pdf - Accepted Version Download (2MB) | Preview
Preview	Text (Figure 2) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Figure 2.pdf - Accepted Version Download (2MB) | Preview
Preview	Text (Figure 3) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Figure 3.pdf - Accepted Version Download (10MB) | Preview
Preview	Text (Figure 4) Van der Merwe_SR_LTN_ACS_Animal_PedRes_Figure 4.pdf - Accepted Version Download (4MB) | Preview
Preview	Text (PRISMA checklist) Van der Merwe_PRISMA_checklist.pdf - Accepted Version Download (88kB) | Preview

Abstract

BACKGROUND: Antenatal corticosteroids (ACSs) are recommended to all women at risk for preterm delivery; currently, there is controversy about the subsequent long-term neurocognitive sequelae. This systematic review summarizes the long-term neurodevelopmental outcomes after ACS therapy in animal models. METHODS: An electronic search strategy incorporating MeSH and keywords was performed using all known literature databases and in accordance with PRISMA guidance (PROSPERO CRD42019119663). RESULTS: Of the 669 studies identified, eventually 64 were included. The majority of studies utilized dexamethasone at relative high dosages and primarily involved rodents. There was a high risk of bias, mostly due to lack of randomization, allocation concealment, and blinding. The main outcomes reported on was neuropathological, particularly glucocorticoid receptor expression and neuron densities, and neurobehavior. Overall there was an upregulation of glucocorticoid receptors with lower neuron densities and a dysregulation of the dopaminergic and serotonergic systems. This coincided with various adverse neurobehavioral outcomes. CONCLUSIONS: In animal models, ACSs consistently lead to deleterious long-term neurocognitive effects. This may be due to the specific agents, i.e., dexamethasone, or the repetitive/higher total dosing used. ACS administration varied significantly between studies and there was a high risk of bias. Future research should be standardized in well-characterized models.

Download activity - last month

Export as XMLCSVJSON

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item